These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2914274)

  • 1. Mesenchymal differentiation of cell lines obtained from human gliomas inoculated into nude mice.
    Jacobsen PF; Papadimitriou JM
    Cancer; 1989 Feb; 63(4):682-92. PubMed ID: 2914274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four permanent cell lines established from human malignant gliomas: three exhibiting striated muscle differentiation.
    Jacobsen PF; Jenkyn DJ; Papadimitriou JM
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):431-50. PubMed ID: 3298555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of experimental meningeal gliomatosis models using nude mice].
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2745-50. PubMed ID: 3753023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines.
    Bullard DE; Schold SC; Bigner SH; Bigner DD
    J Neuropathol Exp Neurol; 1981 Jul; 40(4):410-27. PubMed ID: 7252525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incubation and application of transgenic green fluorescent nude mice in visualization studies on glioma tissue remodeling.
    Dong J; Dai XL; Lu ZH; Fei XF; Chen H; Zhang QB; Zhao YD; Wang ZM; Wang AD; Lan Q; Huang Q
    Chin Med J (Engl); 2012 Dec; 125(24):4349-54. PubMed ID: 23253700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningeal gliomatosis model in nude mice].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Yoshida T; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2600-5. PubMed ID: 3740860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma stem cells involved in tumor tissue remodeling in a xenograft model.
    Dong J; Zhang Q; Huang Q; Chen H; Shen Y; Fei X; Zhang T; Diao Y; Wu Z; Qin Z; Lan Q; Gu X
    J Neurosurg; 2010 Aug; 113(2):249-60. PubMed ID: 20225923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of human glioblastoma cell lines in vitro and their xenografts in nude mice.
    Fischer H; Zeller WJ; Schwechheimer K; Hutter KJ; Wowra B; Kunze S; Sturm V
    Onkologie; 1989 Aug; 12(4):169-74. PubMed ID: 2677876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human glioblastoma cell lines in vitro and their xenografts in nude mice by DNA fingerprinting.
    Türeci O; Fischer H; Lagoda P; Issinger OG
    Onkologie; 1990 Aug; 13(4):305-8. PubMed ID: 2234784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice.
    Bigner SH; Bullard DE; Pegram CN; Wikstrand CJ; Bigner DD
    J Neuropathol Exp Neurol; 1981 Jul; 40(4):390-409. PubMed ID: 7252524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of anticancer agents, growth and chemosensitivity of human tumour xenografts in a segregating stock of AF nude mice.
    Maruo K; Emura R; Ohnishi Y; Endo S; Ueyama Y; Nomura T
    Lab Anim; 1991 Oct; 25(4):342-7. PubMed ID: 1753695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytochemical localization of the GFAP in heterotransplanted human gliomas (author's transl)].
    Maunoury R; Courdi A; Vedrenne C; Constans JP
    Neurochirurgie; 1978; 24(4):221-6. PubMed ID: 215924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cell lines with epithelial cell-like characteristics established from malignant fibrous histiocytomas.
    Roholl PJ; Prinsen I; Rademakers LP; Hsu SM; Van Unnik JA
    Cancer; 1991 Nov; 68(9):1963-72. PubMed ID: 1655231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumoral action of polyamine linked cyclophosphazenes on human malignant glioma heterografts in nu/nu mice.
    Darcel F; Chatel M; Gautris P; Labarre JF
    Anticancer Res; 1990; 10(6):1563-9. PubMed ID: 2285228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
    Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS
    Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor localization of human brain malignant glioma xenograft in nude mice with a radiolabeled monoclonal antibody.
    Lee WH; Yeh MY; Tu YC
    Neurosurgery; 1990 Mar; 26(3):381-90. PubMed ID: 2320206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.